Skip to content

A randomized half-face control study evaluated the efficacy and safety of skin care products combined with mesotherapy

A randomized half-face control study evaluated the efficacy and safety of skin care products combined with mesotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083280
Enrollment
Unknown
Registered
2024-04-19
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging

Interventions

Experimental group:After the mesotherapy treatment, the subjects randomly used the test sample on one side of the face and the basic moisturizing izer on the other side.
Control Group:The control group was non-treatment, and the subjects randomly used the test sample on one side of the face and the base moisturizing izer on the other face.

Sponsors

Cosmetics Testing Center, Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Age: 30-55 years old, and in good health; (2) dry skin; (3) Large pores, dark skin color, rough skin; (4) Face has obvious fine lines; (5) The facial skin state on both sides is consistent and willing to receive water-light needle treatment; (6) Can understand the trial process, voluntarily participate in the trial and sign a written informed consent, willing to actively cooperate with the completion Study content and can maintain a healthy and regular life schedule during the study period.

Exclusion criteria

Exclusion criteria: (1) Women planning to have pregnancy or lactation and within six months postpartum; (2) Oily skin, facial easy to grow acne; (3) Facial skin sensitive acute attack period or other inflammatory skin diseases clinical untreated; (4) Scar constitution or prone to pigmentation; (5) Those who have used retinoA acid, exfoliated skin care products or pharmaceutical preparations within 1 month; (6) Have received medical beauty project treatment (photoelectric, compact, filling, etc.) within 3 months or planned to be in this project period Receiving other medical beauty treatment programs and drugs; (7) Highly sensitive, known to intolerance or allergic to hyaluronic acid or lidocaine; (8) Suffering from active autoimmune diseases, malignant tumors, immune deficiency, severe cardiovascular and cerebrovascular diseases, and serious heart Management disorders or mental illness; (9)Use of antihistamines or other drugs that affect the study results in the past 1 week; (10)Participants who have attended the test site or are participating in other clinical trials in the past 2 months; (11)Other subjects assessed by the investigator for the study; (12)Non-volunteer participants or those unable to complete the prescribed trial content as required.

Design outcomes

Primary

MeasureTime frame
Facial image uptake and analysis;The measurement of transepidermal water loss;The measurement of stratum corneum;The measurement of skin elasticity ;Self-assessment of subject;

Secondary

MeasureTime frame
The measurement of skin gloss degree;The measurement of skin firmness;The visual assessment of investigator;

Countries

China

Contacts

Public ContactYe Li

Dermatology Hospital of Southern Medical University

dlpfbyy@163.com+86 153 6066 6806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026